Sponsor Dossier
JACE Pharma
Sponsor Dossier for JACE Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
JACE Pharma is an Australian Private Company with ABN 98 168 109 215, registered in Queensland and currently active.
Portfolio
JACE Pharma has three brands on the ARTG, all of which are indexable. The portfolio includes three brands with AusPARs on record and one brand with a PBAC outcome. Notable brands include CUPRIOR, EKTERLY, and OXERVATE.
Therapeutic focus
— Rare Disease: 2 brands — Ophthalmology: 1 brand
Regulatory activity
The portfolio's most recent AusPAR was published on 9 October 2025, with three brands holding AusPARs on record. The latest PBAC outcome dates to 1 May 2022, representing one brand with a PBAC outcome on record.